Skip to main content

Clinical Nutrition Market Set to Soar Past USD 22.9 Billion by 2030

The global Clinical Nutrition market size is expected to reach USD 22.9 billion by 2030 and exhibit a CAGR of 5% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of chronic diseases and disorders, growing geriatric population, rising awareness about the importance of proper nutrition in healthcare, advancements in medical research and technology, expanding product portfolios by key players in the market, government initiatives and policies promoting clinical nutrition, are fueling the Market’s growth.

Westford, USA, Jan. 22, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Clinical Nutrition Market, personalized nutrition and nutrigenomics, plant-based and vegan clinical nutrition products, clean label and natural ingredients, digitalization and telehealth in clinical nutrition services, increasing demand for functional foods and supplements, nutraceuticals and medical foods, sustainable and eco-friendly packaging solutions, focus on immune health and gut health, integration of artificial intelligence and machine learning in nutrition assessment and recommendations, are the trends that aid in the market’s growth.

Browse in-depth TOC on “Clinical Nutrition Market”

  • Pages – 165
  • Tables – 97
  • Figures – 74

Clinical nutrition is the application of the science of nutrition to the prevention, diagnosis, and treatment of diseases. It involves the assessment of nutritional status, the development of nutritional interventions, and the education of patients and healthcare providers about nutrition.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/clinical-nutrition-market

Prominent Players in Clinical Nutrition Market

  • Abbott Nutrition
  • Danone Nutricia
  • Fresenius Kabi
  • Nestle Health Science
  • Mead Johnson Nutrition
  • B. Braun Melsungen
  • Baxter International
  • Otsuka Pharmaceutical
  • Ajinomoto Health & Nutrition
  • Royal DSM
  • United Dairy Industry of Michigan
  • Glanbia Nutritionals
  • Arla Foods
  • Kerry Group
  • Mead Johnson Nutrition (China)
  • Abbott Nutrition (China)
  • Nestle Health Science (China)
  • Danone Nutricia (China)
  • Fresenius Kabi (China)
  • Abbott Nutrition (India)

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/clinical-nutrition-market

Oral Nutritional Supplements Demand to Grow Substantially in the Forecast Period

Oral nutritional supplements dominated the global market owing to their ease in administration. It also do not require the insertion of tubes or needles, making them more convenient and preferred by patients who can still tolerate oral intake.

Cancer is the Leading Application Segment 

In terms of application, the cancer is the leading segment due to its high prevalence. In addition, cancer and its treatments often result in various nutritional challenges such as weight loss, malnutrition, reduced appetite, difficulty swallowing, and changes in taste and smell perception. Clinical nutrition plays a crucial role in managing these challenges and improving the overall nutritional status of cancer patients.

North America is the leading Market Due to the Healthcare Infrastructure

Region-wise, North America is one of the largest growing markets with a huge emphasis on healthcare infrastructure. The region has a relatively high prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases. These conditions often require nutritional interventions, leading to a higher demand for clinical nutrition products.

A recent report thoroughly analyzes the major players operating within the Clinical Nutrition market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavors to develop innovative solutions that cater to the ever-increasing demand for Clinical Nutrition.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/clinical-nutrition-market

Key Developments in Clinical Nutrition Market

  • Abbott announced that the U.S. District Court for the Western District of Michigan had revised the recent consent decree, permitting Abbott to release limited amounts of its EleCare specialized amino acid-based products. Abbott and the FDA asked for the consent agreement to be changed so EleCare may be given to sick children.

Key Questions Answered in Clinical Nutrition Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • Can you list the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Pet Supplements Market

Global Citrus Extracts Market

Global Drug of Abuse Testing Market

Global Cedarwood Market

Global CoQ10 Supplement Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.